The prognostic value of Ki-67, as a biomarker for prostate cancer-specific and overall survival, was assessed as a continuous variable, as a grouped variable with limits 0, 1, 5, 10, >10–100 and as a dichotomous variable with a cutoff at ⩽5%. The gene discussed is MKI67; the disease is prostate carcinoma.